BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 527887)

  • 21. Evaluation of a rapid method for determination of total urinary estrogens in morning samples from normally menstruating women.
    Fleetwood L; Shu-rong Z; Eneroth P; Landgren BM
    Contraception; 1983 Apr; 27(4):329-38. PubMed ID: 6851563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R; Alfthan H; Haukkamaa M; Heikinheimo O; Luukkainen T; Lähteenmäki P
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Late luteal phase administration of RU486 for three successive cycles does not disrupt bleeding patterns or ovulation.
    Croxatto HB; Salvatierra AM; Romero C; Spitz IM
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1272-7. PubMed ID: 3119656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
    Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI; Das RP; Madoiya KK; Jain AK; Roy S
    Fertil Steril; 1977 Nov; 28(11):1168-74. PubMed ID: 562781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A; Brache V; Tejada AS; Cochon L; Alvarez-Sanchez F
    Fertil Steril; 1991 Jul; 56(1):27-31. PubMed ID: 1906017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A study of peroxidase levels in human cervical mucus as an index of ovulation.
    Shindler JS; Haworth K; Axon A; Bardsley WG; Tindall VR; Laing I
    J Reprod Fertil; 1977 Nov; 51(2):413-7. PubMed ID: 592293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of daily administration of 0.5 mg. of chlormadinone acetate on plasma levels of follicle-stimulating hormone, luteinizing hormone, and progesterone during the menstrual cycle.
    Saunders DM; Marcus SL; Saxena BB; Beling CG; Connell EB
    Fertil Steril; 1971 May; 22(5):332-44. PubMed ID: 4102481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormonal evaluation of the intrauterine progesterone contraceptive system.
    Bryand-Greenwood GD; Greenwood FC; Hale RW; Morishige WK
    J Clin Endocrinol Metab; 1977 Apr; 44(4):721-7. PubMed ID: 849982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural family planning indicators of ovulation.
    Gross BA
    Clin Reprod Fertil; 1987 Jun; 5(3):91-117. PubMed ID: 3322540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of estrogen-induced discharge of luteinizing hormone in lactating women.
    Baird DT; McNeilly AS; Sawers RS; Sharpe RM
    J Clin Endocrinol Metab; 1979 Oct; 49(4):500-6. PubMed ID: 479342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Temporal relationship and reliability of the clinical, hormonal, and ultrasonographic indices of ovulation in infertile women.
    Luciano AA; Peluso J; Koch EI; Maier D; Kuslis S; Davison E
    Obstet Gynecol; 1990 Mar; 75(3 Pt 1):412-6. PubMed ID: 2406661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An evaluation of teaching cervical mucus symptoms to ovulating infertile women.
    Graham FM; Gosling L; France JT
    Aust N Z J Obstet Gynaecol; 1983 Nov; 23(4):226-30. PubMed ID: 6585197
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lactate dehydrogenase in human cervical mucus: correlation with ovulation, influence of ovarian steroid hormones, and isozyme pattern.
    Takehisa T
    Fertil Steril; 1980 Feb; 33(2):135-40. PubMed ID: 7353690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 'Patient failure' as a reliability model for the 'minipill': a clinical study.
    Nummi S
    Curr Med Res Opin; 1978; 5(5):406-11. PubMed ID: 350492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LH, FSH, estradiol and progesterone levels after discontinuation of hormonal contraception.
    Balogh A; Ditrói F; Lampé LG
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():95-101. PubMed ID: 6242699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Blockade of LH and FSH peaks by low doses of exogenous progesterone in the human female (author's transl)].
    Netter A; Gorins A; Thomas K; Cohen M; Joubinaux J
    Ann Endocrinol (Paris); 1973; 34(4):430-5. PubMed ID: 4779738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of an antiprogesterone (RU486) on the hypothalamic-hypophyseal-ovarian-endometrial axis during the luteal phase of the menstrual cycle.
    Garzo VG; Liu J; Ulmann A; Baulieu E; Yen SS
    J Clin Endocrinol Metab; 1988 Mar; 66(3):508-17. PubMed ID: 2832438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.